Aviceda Therapeutics is a biotech company developing next-generation immunomodulators for ophthalmic conditions using its proprietary HALOS™ nanotechnology platform.

Alentis Therapeutics is a biotech company developing antibody-drug conjugates for treating Claudin-1 positive tumors and organ fibrosis.

Orasis Pharmaceuticals develops and commercializes corrective eye drops for treating presbyopia in adults.

Noetik is an AI-native biotech company that leverages spatial omics data and high-throughput CRISPR technology to develop precision oncology therapies.

Lassen Therapeutics is a clinical-stage biotech company developing novel treatments for fibro-inflammatory diseases and cancer, focusing on therapies targeting the IL-11 and IL-18 pathways.

Odyssey Therapeutics is a biotech firm specializing in developing precision immunomodulators and oncology medicines, with plans to advance multiple therapeutic programs into clinical studies.

RefleXion Medical develops and commercializes SCINTIX therapy, a novel treatment for all stages of indicated solid tumor cancers, including metastatic disease, delivered via the RefleXion X1 platform.

Sanguine Biosciences is a biospecimen procurement services company that empowers patients to accelerate precision medicine and cell and gene therapy research and development.

Avalyn Pharma is a biopharmaceutical company that develops inhalation therapies for rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases, with a focus on creating new inhaled formulations of approved medicines.

Noetik is an AI-native biotech company that leverages spatial omics data and high-throughput CRISPR technology to develop precision oncology therapies.

Star Therapeutics is a biotechnology company that develops first-in-class antibody therapies, primarily for hematology and immunology, and also generates additional biotech companies focused on discovering and advancing novel antibody therapies.

TapestryHealth is a nationwide multi-specialty healthcare company that uses advanced radar technology and AI to evaluate and treat patients in skilled nursing facilities and other post-acute environments, aiming to deliver fully integrated care and improve patient outcomes.